Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF in HBV-Infected Pregnant Women
NCT05853718Phase 4Recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- May 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by Hangzhou First People's Hospital. Started May 2021; status: recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05853718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853718.